Fortive Q3 2026 earnings
Revenue growth accelerated to 7.8% YoY, adjusted EPS grew 13.2% YoY, and adjusted EBITDA margin expanded 50 bps YoY.
Headline numbers
| Metric | Actual | YoY | QoQ | 8-K location |
|---|---|---|---|---|
| Revenue | $1.11B | +7.8% | — | Ex. 99.1, income statement |
| EPS (GAAP) | $0.57 | +62.9% | — | Ex. 99.1, income statement |
| EPS (adjusted) | $0.77 | +13.2% | — | Ex. 99.1, income statement |
| Net income | $173M | +47.4% | — | Ex. 99.1, income statement |
| Adj. EBITDA | $339M | +9.5% | — | Ex. 99.1, income statement |
| Adj. EBITDA margin | 30.6% | +0.5 pp | — | Ex. 99.1, income statement |
Revenue breakdown
| Segment | Actual | YoY | Share of revenue | Note |
|---|---|---|---|---|
| Intelligent Operating Solutions | 7.9% core growth | +9.1% core growth | — | Excluding acquisitions and currency |
| Advanced Healthcare Solutions | 3.7% core growth | +3.1% core growth | — | Excluding acquisitions and currency |
Margins and costs
- Gross margin not stated in the 8-K
- Operating expenses SG&A $406.5M (+4.7% YoY), R&D $68.2M (+9.8% YoY)
- One-offs in the quarter Pretax IEEPA tariff refunds ($18M); Pretax foreign currency transaction losses ($4.9M); Pretax capitalized software impairment ($6.2M); Pretax acquisition, divestiture, and Separation related items ($1M)
- Effective tax rate 17.2% (prior-year 13.3%)
- Non-GAAP bridge Adds back amortization ($89.3M), acquisition/divestiture/Separation items ($1M), restructuring charges ($1.5M), foreign currency losses ($4.9M), tariff refunds ($18M), and capitalized software impairment ($6.2M).
KPIs
| Metric | Actual | Prior quarter | Prior year | Change |
|---|---|---|---|---|
| Free cash flow | $284M | $271M | $266M | +4.8% YoY |
| TTM GAAP operating cash flow | $1.18B | $1.16B | $1.02B | +15.5% YoY |
| TTM free cash flow | $1.06B | $1.04B | $922M | +15.2% YoY |
Guidance
| Metric | Guide | Prior guide | Change |
|---|---|---|---|
| FY 2026 adjusted EPS | $3.10 to $3.14 | $2.95 to $3.05 | +15% YoY at midpoint |
What drove it
- Revenue story Revenue grew 7.8% YoY, with core growth accelerating to 7.2% YoY; Intelligent Operating Solutions grew 9.1% core YoY and Advanced Healthcare Solutions grew 3.1% core YoY.
- EPS story Adjusted EPS grew 13.2% YoY, driven by revenue growth, margin expansion, and favorable tax rates.
- One-off check Pretax IEEPA tariff refunds ($18M) and foreign currency losses ($4.9M) are one-offs.
The good
- Revenue growth accelerated to 7.8% YoY
- Adjusted EBITDA margin expanded 50 bps YoY
- Adjusted EPS grew 13.2% YoY
- TTM free cash flow grew 15.2% YoY
The bad
- Advanced Healthcare Solutions core growth slowed to 3.1% YoY
- Adjusted EPS growth decelerated to 13.2% YoY from 28.5% YoY in Q2
The ugly
- none
Open questions
- What is the specific impact of the capitalized software impairment?
- How will the IEEPA tariff refunds affect future margins?
Full release
Earnings: FTV — filed 2026-10-28
Fortive Reports Third Quarter 2026 Results
• Q3 revenue growth accelerated to 7.8% year-over-year on a reported basis and 7.2% on a core basis
• Delivered Q3 GAAP diluted EPS of $0.57, up 63% year-over-year, and adjusted diluted EPS of $0.77, up 13% year-over-year
• Completed ~$300 million of share repurchases in Q3, bringing total share repurchases since the launch of new Fortive to ~$2.3 billion, representing ~43 million shares or ~13% of shares outstanding
• Raising our FY 2026 adjusted EPS guidance range to $3.10 to $3.14, up ~15% year-over-year at the midpoint
EVERETT, WA, October 28, 2026 - Fortive Corporation (“Fortive”) (NYSE: FTV) today announced financial results for the third quarter of 2026.
“Q3 was another quarter of strong and accelerating performance for Fortive. We delivered over 7% core growth, approximately 10% adjusted EBITDA growth, and 13% adjusted EPS growth, representing our fifth consecutive quarter of double-digit adjusted EPS growth. We are executing our Fortive
Accelerated strategy and continue to see growing evidence that our investments in innovation acceleration, commercial acceleration, and recurring customer value are contributing to faster revenue growth and strong financial performance,” said Olumide Soroye, President and CEO.
“We are raising our full-year adjusted EPS guidance to $3.10 to $3.14, reflecting our strong year-to-date performance and our confidence in the trajectory of the business. We remain fully confident in our ability to deliver on the medium-term financial framework we shared at our last Investor Day. We are excited about our progress and continue to see meaningful opportunities to accelerate profitable growth, deploy capital with discipline and build investor trust to unlock the significant shareholder value creation opportunity ahead of us,” Mr. Soroye concluded.
Financial Highlights for Third Quarter 2026
• Revenue of $1.11 billion, up 7.8% year-over-year; core revenue up 7.2%
• GAAP net earnings of $173 million, up 47.4% year-over-year, GAAP net earnings margin of 15.6%; adjusted EBITDA of $339 million, up 9.5% year-over-year, adjusted EBITDA margin of 30.6%
• GAAP diluted EPS of $0.57, up 62.9% year-over-year; adjusted diluted EPS of $0.77, up 13.2% year-over-year
• GAAP operating cash flow of $313 million, Trailing Twelve Months (TTM) GAAP operating cash flow of $1,177 million; free cash flow of $284 million, TTM free cash flow of $1,062 million
• Deployed ~$300 million towards share repurchases, representing ~5 million shares or ~2% of diluted shares outstanding
Raising Full Year 2026 Guidance
For FY 2026, Fortive now expects adjusted diluted earnings per share of $3.10 to $3.14.¹
Summary Financial Results, Continuing Operations
Summary Financial Results by Segment, Continuing Operations
PRECISION TECHNOLOGIES SEPARATION
On June 28, 2025 (the “Distribution Date”), the Company completed the separation (the “Separation” or the “PT Separation”) of its former Precision Technologies segment by distributing to Fortive shareholders on a pro rata basis all of the issued and outstanding common stock of Ralliant Corporation (“Ralliant”), the entity incorporated to hold the PT businesses. The requirements for reporting the Ralliant business as discontinued operations were met upon completion of the PT Separation. Unless otherwise indicated, all amounts herein refer to continuing operations.²
CONFERENCE CALL DETAILS
Fortive will discuss results and outlook during its quarterly investor conference call today starting at 12:00 p.m. ET. The call and an accompanying slide presentation will be webcast on the “Investors” section of Fortive’s website, www.fortive.com, under “News & Events.” A replay of the webcast will be available at the same location shortly after the conclusion of the presentation.
You can access the conference call by dialing 877-407-3110 within the U.S. or +1 215-268-9915 outside the U.S. a few minutes before 12:00 p.m. ET and notifying the operator that you are dialing in for Fortive’s earnings conference call.
Fortive’s earnings press release, presentation, and other related materials will be posted to the "Investors" section of Fortive’s website under "Financial Info.”
ABOUT FORTIVE
Fortive innovates essential technologies to keep our world safe and productive. Fortive’s strategic segments - Intelligent Operating Solutions and Advanced Healthcare Solutions - include iconic inventor brands with leading positions in their markets. The company’s businesses design, develop, manufacture, and market products, software, and services, building on leading brand names, innovative technologies, and strong market positions. Fortive is headquartered in Everett, Washington and employs a team of more than 10,000 research and development, manufacturing, sales, distribution, service, and administrative team members in approximately 50 countries around the world. With a culture rooted in continuous improvement, the core of our company’s operating model is the Fortive Business System. For more information please visit: www.fortive.com.
NON-GAAP FINANCIAL MEASURES... (truncated)s, but should instead be read in conjunction with the GAAP financial measures. The non-GAAP financial measures used by Fortive in this release may be different from similarly-titled non-GAAP measures used by other companies. With respect to forward-looking non-GAAP measures, we have not reconciled with, or presented, corresponding forward-looking GAAP measures since doing so would require us to make assumptions with precision about acquisitions, currency translations, capital and other expenses and other similar adjustments during the future periods.
Financial statements
Income Statement
Fortive Continuing Operations — , Continuing Operations
| Q3-26 | Q3-25 | Variance | |
|---|---|---|---|
| Revenue | $1,108M | $1,027M | 7.8% / 7.2% (reported / core) |
| GAAP net earnings | $173M | $117M | 47.4% |
| GAAP net earnings margin | 15.6% | 11.4% | 420 bps |
| Adj. EBITDA | $339M | $309M | 9.5% |
| Adj. EBITDA margin | 30.6% | 30.1% | 50 bps |
| GAAP diluted earnings per share | 0.57 | 0.35 | 62.9% |
| Adj. diluted earnings per share | 0.77 | 0.68 | 13.2% |
| GAAP operating cash flow | $313M | $295M | 6.3% |
| Free cash flow | $284M | $266M | 6.7% |
| TTM GAAP operating cash flow | $1,177M | $1,019M | 15.5% |
| TTM free cash flow | $1,062M | $922M | 15.2% |
Income Statement
Three Months Ended — (unaudited)
| Three Months Ended – October 2, 2026 | Three Months Ended – September 26, 2025 | Nine Months Ended – October 2, 2026 | Nine Months Ended – September 26, 2025 | ||
|---|---|---|---|---|---|
| Sales | 1,107.5 | 1,027.1 | 3,273.7 | 3,036.6 | |
| Cost of sales | -396.9 | -377.9 | -1,192.3 | -1,104.4 | |
| Gross profit | 710.6 | 649.2 | 2,081.4 | 1,932.2 | |
| Operating costs: | Selling, general and administrative | -406.5 | -427.6 | -1,241.7 | -1,244.3 |
| Operating costs: | Research and development | -68.2 | -62 | -202.2 | -193.2 |
| Operating costs: | Operating profit | 235.9 | 159.6 | 637.5 | 494.7 |
| Non-operating income (expense), net: | Interest expense, net | -38.8 | -25.4 | -105.8 | -89.5 |
| Non-operating income (expense), net: | Other non-operating income, net | 5.2 | 0.8 | 13.7 | 3.1 |
| Non-operating income (expense), net: | Earnings from continuing operations before income taxes | 202.3 | 135 | 545.4 | 408.3 |
| Non-operating income (expense), net: | Income taxes | -29.8 | -18 | -79.2 | -67.1 |
| Non-operating income (expense), net: | Net earnings from continuing operations | 172.5 | 117 | 466.2 | 341.2 |
| Non-operating income (expense), net: | Net earnings from discontinued operations | -62 | 52.3 | ||
| Non-operating income (expense), net: | Net earnings | 172.5 | 55 | 466.2 | 393.5 |
| Net earnings per common share from continuing operations: | Basic | 0.57 | 0.35 | 1.53 | 1.01 |
| Net earnings per common share from continuing operations: | Diluted | 0.57 | 0.35 | 1.51 | 1 |
| Net earnings per common share from discontinued operations: | Basic | -0.19 | 0.16 | ||
| Net earnings per common share from discontinued operations: | Diluted | -0.19 | 0.15 | ||
| Net earnings per share: | Basic | 0.57 | 0.17 | 1.53 | 1.17 |
| Net earnings per share: | Diluted | 0.57 | 0.16 | 1.51 | 1.16 |
| Average common stock and common equivalent shares outstanding: | Basic | 300.4 | 330.8 | 304.7 | 337.2 |
| Average common stock and common equivalent shares outstanding: | Diluted | 303.9 | 333.4 | 308.2 | 339.9 |
Income Statement
Three Months Ended October 2, 2026 — Core Revenue Growth (unaudited)
| Three Months Ended October 2, 2026 – Intelligent Operating Solutions | Three Months Ended October 2, 2026 – Advanced Healthcare Solutions | Three Months Ended October 2, 2026 – Total Fortive | ||
|---|---|---|---|---|
| Total Revenue Growth (GAAP) | 9.8 | 3.7 | 7.8 | |
| Excluding impact of: | Acquisitions and divestitures | -0.4 | -0.5 | -0.5 |
| Excluding impact of: | Currency exchange rates | -0.3 | -0.1 | -0.1 |
| Excluding impact of: | Core Revenue Growth (Non-GAAP) | 9.1 | 3.1 | 7.2 |
Income Statement
Three Months Ended — Adjusted EBITDA and Adjusted EBITDA Margin from Continuing Operations (unaudited) (in millions)
| Three Months Ended – October 2, 2026 | Three Months Ended – October 2, 2026 | Three Months Ended – September 26, 2025 | Three Months Ended – September 26, 2025 | |
|---|---|---|---|---|
| Revenue (GAAP) | 1,107.5 | 1,027.1 | ||
| Net Earnings from Continuing Operations (GAAP) | 172.5 | 117 | ||
| Interest expense, net | 38.8 | 25.4 | ||
| Income taxes | 29.8 | 18 | ||
| Depreciation | 22.6 | 17.6 | ||
| Amortization | 89.3 | 91.5 | ||
| EBITDA (Non-GAAP) | 353 | 269.5 | ||
| Pretax acquisition, divestiture, and Separation related items (a) | 1 | 38.3 | ||
| Pretax discrete restructuring charges | 1.5 | 2.1 | ||
| Pretax foreign currency transaction (gains) and losses related to Euro-denominated debt | -4.9 | -0.5 | ||
| Pretax IEEPA tariff refunds | -18 | |||
| Pretax capitalized software impairment | 6.2 | |||
| Adjusted EBITDA (Non-GAAP) | 338.8 | 309.4 | ||
| Net Earnings Margin from Continuing Operations (GAAP) | 15.6 | % | 11.4 | % |
| Adjusted EBITDA Margin (Non-GAAP) | 30.6 | % | 30.1 | % |
Income Statement
Three Months Ended — Adjusted Net Earnings and Adjusted Diluted Earnings Per Share from Continuing Operations (unaudited) ($ in millions, except per share amounts)
| Three Months Ended – October 2, 2026 | Three Months Ended – October 2, 2026 – Per share values | Three Months Ended – September 26, 2025 | Three Months Ended – September 26, 2025 – Per share values | |
|---|---|---|---|---|
| Net Earnings and Earnings Per Share from Continuing Operations (GAAP) | 172.5 | 0.57 | 117 | 0.35 |
| Pretax amortization of acquisition related intangible assets | 89.3 | 0.29 | 91.5 | 0.27 |
| Pretax acquisition, divestiture, and Separation related items (a) | 1 | 38.3 | 0.11 | |
| Pretax discrete restructuring charges | 1.5 | 2.1 | 0.01 | |
| Pretax foreign currency transaction (gains) and losses related to Euro-denominated debt | -4.9 | -0.02 | -0.5 | |
| Pretax IEEPA tariff refunds | -18 | -0.06 | ||
| Pretax capitalized software impairment | 6.2 | 0.02 | ||
| Tax effect of the adjustments reflected above | -12.2 | -0.03 | -20.1 | -0.06 |
| Adjusted Net Earnings and Adjusted Earnings Per Share from Continuing Operations (Non-GAAP) | 235.4 | 0.77 | 228.3 | 0.68 |
| Average Common Diluted Stock Outstanding (shares in millions) | 303.9 | 333.4 |
Balance Sheet
($ and shares in millions, except per share amounts)
| As of – October 2, 2026 – (unaudited) | As of – December 31, 2025 | ||
|---|---|---|---|
| Current assets: | Cash and equivalents | 377.3 | 375.5 |
| Current assets: | Accounts receivable less allowance for doubtful accounts of $19.9 and $18.8, respectively | 669.5 | 683.6 |
| Inventories: | Finished goods | 183.9 | 169.9 |
| Inventories: | Work in process | 13 | 12.3 |
| Inventories: | Raw materials | 118.3 | 109.6 |
Cash Flow
Nine Months Ended — (unaudited)
| Nine Months Ended – October 2, 2026 | Nine Months Ended – September 26, 2025 | ||
|---|---|---|---|
| Cash flows from operating activities: | Net earnings | 466.2 | 393.5 |
| Cash flows from operating activities: | Less: net earnings from discontinued operations | -52.3 | |
| Cash flows from operating activities: | Net earnings from continuing operations | 466.2 | 341.2 |
| Adjustments to reconcile net earnings to net cash provided by operating activities: | Amortization | 274 | 274.3 |
| Adjustments to reconcile net earnings to net cash provided by operating activities: | Depreciation | 65 | 52 |
| Adjustments to reconcile net earnings to net cash provided by operating activities: | Stock-based compensation | 66.1 | 96.9 |
| Change in certain assets and liabilities: | Change in accounts receivable, net | 11.2 | 56.2 |
| Change in certain assets and liabilities: | Change in inventories | -25.6 | -40.2 |
| Change in certain assets and liabilities: | Change in trade accounts payable | -10.3 | -4.1 |
| Change in certain assets and liabilities: | Change in prepaid expenses and other assets | 17.8 | -28 |
| Change in certain assets and liabilities: | Change in accrued expenses and other liabilities | -32 | -56.8 |
| Change in certain assets and liabilities: | Total operating cash provided by continuing operations | 832.4 | 691.5 |
| Change in certain assets and liabilities: | Total operating cash provided by discontinued operations | 1.8 | 25.8 |
| Change in certain assets and liabilities: | Net cash provided by operating activities | 834.2 | 717.3 |
| Cash flows from investing activities: | Purchases of property, plant and equipment | -84.2 | -74.7 |
| Cash flows from investing activities: | Cash paid for acquisitions, net of cash received | -58.1 | |
| Cash flows from investing activities: | All other investing activities | 7.2 | 11.2 |
| Cash flows from investing activities: | Total investing cash used in continuing operations | -135.1 | -63.5 |
| Cash flows from investing activities: | Total investing cash used in discontinued operations | -15.7 | |
| Cash flows from investing activities: | Net cash used in investing activities | -135.1 | -79.2 |
| Cash flows from financing activities: | Net proceeds from commercial paper borrowings | 455.7 | 105.8 |
| Cash flows from financing activities: | Repurchase of common shares | -1,000.4 | -1,338.2 |
| Cash flows from financing activities: | Payment of dividends | -57.3 | -73.4 |
| Cash flows from financing activities: | Proceeds from borrowings (maturities greater than 90 days), net of issuance costs | 1,088 | |
| Cash flows from financing activities: | Repayment of borrowings (maturities greater than 90 days) | -1,192.9 | -715.7 |
| Cash flows from financing activities: | Proceeds from Ralliant Dividend | 1,150 | |
| Cash flows from financing activities: | All other financing activities | -0.6 | 8.7 |
| Cash flows from financing activities: | Total financing cash used in continuing operations | -707.5 | -862.8 |
| Cash flows from financing activities: | Total financing cash used in discontinued operations | -160.3 | |
| Cash flows from financing activities: | Net cash used in financing activities | -707.5 | -1,023.1 |
| Cash flows from financing activities: | Effect of exchange rate changes on cash and equivalents | 10.2 | 2.5 |
| Cash flows from financing activities: | Net change in cash and equivalents | 1.8 | -382.5 |
| Cash flows from financing activities: | Beginning balance of cash and equivalents | 375.5 | 813.3 |
| Cash flows from financing activities: | Ending balance of cash and equivalents | 377.3 | 430.8 |
Cash Flow
Three Months Ended — Free Cash Flow from Continuing Operations - Trailing Twelve Months (unaudited) (in millions)
| Three Months Ended – October 2, 2026 | Three Months Ended – July 3, 2026 | Three Months Ended – April 3, 2026 | Three Months Ended – December 31, 2025 | Trailing Twelve Months | |
|---|---|---|---|---|---|
| Operating Cash Flows from Continuing Operations (GAAP) | 313.3 | 298.7 | 220.4 | 344.2 | 1,176.6 |
| Less: Purchases of property, plant & equipment (capital expenditures) (GAAP) | -29.5 | -28.1 | -26.6 | -30.4 | -114.6 |
| Free Cash Flow (Non-GAAP) | 283.8 | 270.6 | 193.8 | 313.8 | 1,062 |
FORWARD-LOOKING STATEMENTS
Statements in this release that are not strictly historical, including statements regarding anticipated financial results, industry trends, the ability to execute the planned strategies, future prospects, shareholder value, and any other statements identified by their use of words like “anticipate,” “expect,” “believe,” “outlook,” “guidance,” "target", or “will” or other words of similar meaning, are “forward-looking statements" within the meaning of the United States federal securities laws. Factors that could cause actual results to differ materially from those in the forward-looking statements include, among other things: deterioration of or instability in the economy, the markets we serve, international trade policies and deteriorating trade relations with other countries, including imposition of tariffs and retaliatory tariffs between United States and China and other countries, responsive economic nationalism, trade restrictions, and enhanced regulation, impact of any prolonged government shutdown, the financial markets, geopolitical conditions and conflicts including in the Middle East and in Ukraine, security breaches, data exfiltration, or other disruptions of our information technology systems, supply chain constraints, our ability to adjust purchases and manufacturing capacity to reflect market conditions, impact of development, deployment, and use of artificial intelligence, reliance on sole sources of supply, contractions or lower growth rates and cyclicality of markets we serve, competition, changes in industry standards and governmental regulations, our ability to recruit and retain key employees, our ability to successfully identify, consummate, integrate and realize the anticipated value of appropriate acquisitions or otherwise effectively deploy our capital, our ability to develop and successfully market new products, software, and services and expand into new markets, the potential for improper conduct by our employees, agents or business partners, contingent liabilities relating to acquisitions and divestitures, impact of changes to tax laws, our compliance with applicable laws and regulations and changes in applicable laws and regulations, risks relating to³ international economic, geopolitical, including war and sanctions, legal, compliance and business factors, risks relating to potential impairment of goodwill and other intangible assets, currency exchange rates, tax audits and changes in our tax rate and income tax liabilities, the impact of our debt obligations on our operations, litigation and other contingent liabilities including intellectual property and environmental, health and safety matters, our ability to adequately protect our intellectual property rights, risks relating to product, service or software defects, product liability and recalls, risks relating to product manufacturing, our relationships with and the performance of our channel partners, commodity costs and surcharges, adverse effects of restructuring activities, risk related to tax treatment of our prior separations, impact of our indemnification obligation to Ralliant and Vontier, impact of changes to U.S. GAAP, labor matters, and disruptions relating to man-made and natural disasters and climate change. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in our SEC filings, including our Annual Report on Form 10-K for the year ended December 31, 2025 and Quarterly Reports on Form 10-Q for the subsequent quarters. These forward-looking statements speak only as of the date of this release, and Fortive does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise.
INVESTOR CONTACT
Christina Jones
Vice President, Investor Relations
Fortive Corporation
6920 Seaway Boulevard
Everett, WA 98203
Telephone: (425) 446-5000
Email: investors@fortive.com⁴